��ѻ��ý

Nearly two years into the pandemic, there's still debate on using convalescent plasma to treat COVID.

A group of Bloomberg School researchers are helping Maryland’s overdose programs implement data-driven solutions to the overdose epidemic.

Shaun Truelove, PhD, MPH, talks about the COVID-19 Scenario Modeling Hub’s recent projections of what COVID-19 might look like in early 2022.

Associate Scientist Megan Latshaw, PhD, co-led a team looking at transit, health and equity

While new data show that vaccinated people can carry high viral loads of SARS-CoV-2, vaccines still prevent the worst outcomes from COVID-19.

The future of the pandemic depends a lot on what we do this summer.

Most of us must have seen the horrific scenes from India that have followed the severe second wave of COVID-19. India’s neighbor, Nepal, is now going through a similar, if not worse, humanitarian crisis due to COVID-19.

Researchers at the Johns ��ѻ��ý have developed a series of case studies for urgent public health issues to help students and practitioners across the U.S. learn how to apply big-data analysis approaches in their work.

Why 10%–20% of people with COVID-19 are responsible for a large share of the disease’s spread.

Strategies for better trial design could streamline and accelerate testing of new treatments.

Evidence-based recommendations for protecting from COVID-19 all of the people who touch the criminal justice system, including incarcerated and detained people, staff, and jurors.